Maravai LifeSciences Holdings, Inc. Class A Common Stock Earnings Dividend

Maravai LifeSciences Holdings, Inc. Class A Common Stock’s revenue jumped 8.53% since last year same period to $51.44Mn in the Q2 2026. On a quarterly growth basis, Maravai LifeSciences Holdings, Inc. Class A Common Stock has generated -21.86% fall in its revenue since last 3-months.

Maravai LifeSciences Holdings, Inc. Class A Common Stock’s net profit jumped 68.64% since last year same period to $-12.42Mn in the Q2 2026. On a quarterly growth basis, Maravai LifeSciences Holdings, Inc. Class A Common Stock has generated -232.6% fall in its net profits since last 3-months.

Maravai LifeSciences Holdings, Inc. Class A Common Stock’s net profit margin jumped 71.11% since last year same period to -24.14% in the Q2 2026. On a quarterly growth basis, Maravai LifeSciences Holdings, Inc. Class A Common Stock has generated -325.67% fall in its net profit margins since last 3-months.

Maravai LifeSciences Holdings, Inc. Class A Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a -40% fall from last quarter’s estimates.

Maravai LifeSciences Holdings, Inc. Class A Common Stock’s earning per share (EPS) estimates for the current year stand at -0.07.

Maravai LifeSciences Holdings, Inc. Class A Common Stock’s earning per share (EPS) jumped 12.5% since last year same period to -0.07 in the Q2 2026. This indicates that the Maravai LifeSciences Holdings, Inc. Class A Common Stock has generated 12.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.